TRUS GUIDED PROSTATE BIOPSY

A TRUS Guided Prostate Biopsy (Transrectal Ultrasound-Guided Prostate Biopsy) is a specialized diagnostic procedure used to collect small tissue samples from the prostate gland for microscopic examination. It is considered one of the most effective methods for diagnosing prostate cancer and evaluating abnormal findings in the prostate.

The procedure uses transrectal ultrasound (TRUS) imaging to visualize the prostate gland in real time. A thin biopsy needle is guided through the rectal wall into specific areas of the prostate to obtain tissue samples. These samples are then sent to a pathology laboratory where they are examined for cancer cells, precancerous changes, inflammation, or other prostate abnormalities.

TRUS-guided biopsy is commonly recommended when a patient has an elevated Prostate-Specific Antigen (PSA) level, an abnormal digital rectal examination (DRE), suspicious imaging findings, or ongoing concerns about prostate disease.

Benefits of the Test

• Helps diagnose prostate cancer accurately
• Identifies abnormal prostate tissue changes
• Assists in determining cancer grade and severity
• Supports treatment planning and prognosis assessment
• Helps distinguish cancer from benign prostate conditions

Why Doctors Recommend This Test

Doctors recommend a TRUS Guided Prostate Biopsy when there is suspicion of prostate cancer or significant prostate abnormalities. It is commonly used in:

• Elevated PSA level evaluation
• Abnormal digital rectal examination findings
• Suspicious prostate MRI findings
• Monitoring patients at high risk for prostate cancer
• Assessment of persistent prostate abnormalities
• Confirmation of prostate cancer diagnosis

The biopsy provides direct tissue evidence and remains the definitive method for confirming prostate cancer.

Preparation Before Test

Patients are usually advised to:

• Inform their doctor about medications and medical conditions
• Stop blood-thinning medications if instructed
• Take prescribed antibiotics before and after the procedure
• Use bowel preparation if recommended
• Follow specific dietary instructions provided by the healthcare team

Preparation requirements may vary depending on the physician and healthcare facility.

Normal Reporting Time

The typical reporting time is 5 to 7 working days, depending on tissue processing and pathological evaluation requirements.

Who Should Take This Test

• Men with elevated PSA levels
• Patients with abnormal prostate examination findings
• Individuals with suspicious prostate imaging results
• Men at increased risk of prostate cancer
• Patients requiring confirmation of prostate disease

TRUS Guided Prostate Biopsy is a vital diagnostic procedure in modern urology. By providing tissue samples directly from the prostate gland, it allows accurate diagnosis, grading, and management of prostate cancer and other prostate disorders.

Clinical Significance

A TRUS Guided Prostate Biopsy may help diagnose:

• Prostate cancer
• Prostatic intraepithelial neoplasia (PIN)
• Atypical small acinar proliferation (ASAP)
• Benign prostatic hyperplasia (BPH)
• Chronic prostatitis
• Prostate inflammation
• Other prostate gland abnormalities

Pathology findings often include a Gleason Score or Grade Group, which helps determine the aggressiveness of prostate cancer and guide treatment decisions.